IndiaRF to acquire API and CRAMS business of Ind-Swift Laboratories Limited for INR 1,650 Crores
Bangalore: The Board of Directors of Ind-Swift Laboratories Limited (“Ind-Swift”) on September 6th 2023 approved a business transfer of its active pharmaceutical ingredients (“API”) and contract research and manufacturing services!-->…
Read More...
Read More...